Azitra (AZTR) | Q2 2023 | 12,999,900% |
Lottery (SEGG) | Q2 2023 | 250,532.91% |
Foremost Lithium Resource & Technology Ltd Common stock (FMST) | Q2 2023 | 3,328% |
CXApp (CXAI) | Q2 2023 | 520.45% |
Minerva Neurosciences (NERV) | Q2 2023 | 457.32% |
Marker Therapeutics (MRKR) | Q2 2023 | 324.66% |
Applied Digital (APLD) | Q2 2023 | 311.89% |
CalciMedica, Inc Common Stock (CALC) | Q2 2023 | 301% |
Dogwood Therapeutics (DWTX) | Q2 2023 | 287.1% |
Aemetis (AMTX) | Q2 2023 | 207.98% |
Rockwell Medical (RMTI) | Q2 2023 | 201.66% |
Eyepoint Pharmaceuticals (EYPT) | Q2 2023 | 196.93% |
D-Wave Quantum (QBTS) | Q2 2023 | 195.2% |
Scienture (SCNX) | Q2 2023 | 190% |
Wearable Devices (WLDS) | Q2 2023 | 188.89% |
Context Therapeutics (CNTX) | Q2 2023 | 185.71% |
Xcel Brands (XELB) | Q2 2023 | 182.3% |
GSI Technology (GSIT) | Q2 2023 | 179.29% |
ICZOOM Group Inc Class A Ordinary Shares (IZM) | Q2 2023 | 178.99% |
DiaMedica Therapeutics (DMAC) | Q2 2023 | 178.71% |
Applied Opt (AAOI) | Q2 2023 | 178.5% |
Prairie Operating Co Common Stock (PROP) | Q2 2023 | 172.73% |
Black Diamond Therapeutics (BDTX) | Q2 2023 | 171.51% |
UTime (WTO) | Q2 2023 | 169.41% |
Nano X Imaging (NNOX) | Q2 2023 | 168.92% |
